Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Goldman Sachs Maintains Neutral on AvePoint, Raises Price Target to $17

Author: Benzinga Newsdesk | May 12, 2025 12:58pm
Goldman Sachs analyst Gabriela Borges maintains AvePoint (NASDAQ:AVPT) with a Neutral and raises the price target from $15 to $17.

Posted In: AVPT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist